Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs

Anti-angiogenic therapies were approved for different cancers. However, significant primary and secondary resistance hampers efficacy in several tumor types including breast cancer. Thus, we need to develop clinically applicable strategies to enhance efficacy of anti-angiogenic drugs. We report that...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben-Batalla, Isabel, Cubas-Cordova, Miguel, Udonta, Florian, Wroblewski, Mark, Waizenegger, Jonas S., Janning, Melanie, Sawall, Stefanie, Gensch, Victoria, Zhao, Lin, Martinez-Zubiaurre, Iñigo, Riecken, Kristoffer, Fehse, Boris, Pantel, Klaus, Bokemeyer, Carsten, Loges, Sonja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467441/
https://www.ncbi.nlm.nih.gov/pubmed/25849942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467441/
https://www.ncbi.nlm.nih.gov/pubmed/25849942

Ejemplares similares